Engineered Reverse Transcriptase for High-Temperature Long cDNA Synthesis
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current reverse transcriptase enzymes face limitations in detection sensitivity, specificity, side enzyme activities, enzyme stability, and synthesis capacity, particularly when dealing with RNA templates of varying lengths and secondary structures.
Innovation Solution
Engineered reverse transcriptase enzymes, derived from equine infectious anemia virus (EIAV RT), with specific mutations in the thumb, connection, and RNase H domains, enhance thermal stability and eliminate RNase H activity, allowing cDNA synthesis up to 65°C and beyond.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Stability of the object's composition
If reverse transcriptase enzymes are used at elevated temperatures to improve thermal stability and analyze highly structured RNA targets, then enzyme stability improves, but synthesis capacity and detection sensitivity deteriorate
Solution Approach 1:
The patent applies parameter changes by modifying amino acid residues in the reverse transcriptase enzyme structure (specifically in the thumb, connection, and RNase H domains) to alter the enzyme's thermal stability parameters while maintaining its catalytic activity at elevated temperatures up to 65°C
Solution Approach 2:
The patent extracts and eliminates the RNase H side activity from the reverse transcriptase enzyme through targeted mutagenesis, removing this interfering function while preserving the main reverse transcription capability at high temperatures
2Adaptability or versatility
If RNase H activity is present in reverse transcriptase enzymes, then RNA digestion function is provided, but cDNA synthesis fidelity and length deteriorate due to interference with RNA template
Solution Approach 1:
The patent extracts and eliminates the RNase H side activity from the reverse transcriptase enzyme through targeted mutagenesis, removing this interfering function while preserving the main reverse transcription capability
Solution Approach 2:
The patent segments the enzyme functions by separating the reverse transcription activity from the RNase H activity, allowing independent optimization of each function through domain-specific mutagenesis
3Measurement precision
If reverse transcriptase enzymes are used to synthesize long cDNAs from structured RNA templates, then detection sensitivity improves, but enzyme processivity and thermostability deteriorate
Solution Approach 1:
The patent changes the structural parameters of the reverse transcriptase enzyme through amino acid substitutions in key domains, enhancing both processivity and thermostability to enable sustained synthesis of long cDNA products
Solution Approach 2:
The patent creates a composite enzyme structure by combining multiple mutated domains (thumb, connection, RNase H) with complementary functions, resulting in an engineered enzyme with enhanced overall performance for long-range synthesis
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The engineered enzymes improve cDNA synthesis capacity, thermal stability, and eliminate secondary enzymatic activity, enabling the synthesis of cDNAs over 12 kb in length at elevated temperatures, enhancing the reliability of RNA analysis methods like RT-PCR and RNA-Seq.
Implementation Method 1
reverse transcriptase enzymes to catalyze the synthesis of complementary DNA (cDNA) using an RNA template
Implementation Method 2
eliminate RNase H activity, allowing cDNA synthesis up to 65°C and beyond
Data Source
Figure 1
Figure 2(a)~2(b)
Figure 3
AI summary
The present invention provides engineered reverse transcriptase enzymes that afford beneficial improvements in thermal stability, processivity, cDNA yields and elimination of secondary enzymatic activity. The present invention also provides methods for amplifying template nucleic acids using such reverse transcriptase enzymes. This invention addresses deficiencies in the current state of the art reverse transcriptase enzymes in RNA detection and analysis including deficiencies in detection sensitivity, specificity, side enzyme activities, enzyme stability and synthesis capacity, especially when using template nucleic acids ranging in length, secondary structure and nucleotide content. The invention provides variants of the equine infectious anemia virus (EIAV) RT with mutations that eliminate RNase H activity, substitutions in the minor groove binding track (MBGT) of the thumb domain or substitutions in the RT's connection domain.